Eisai Co., Ltd. has announced that Eisai’s subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsid...
Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...
Can you throw some light on your recent expansion in Delhi-NCR? mfine is an AI powered, on-demand healthcare platform ...
Zebra Medical Vision, the deep learning medical imaging analytics company, has announced its partnership with Medsy...
Biocon Ltd, Asia’s premier biopharmaceuticals company, has announced that it has signed a License and Supply Agree...
Nobel laureates and world-leading experts will meet in Delhi and Punjab India, to address the topic of “Teaching a...
The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and transfe...
Indian Pharma major Lupin Limited (Lupin) on 9 Sep 2019, announced that it has received approval for its Ethacrynic Acid...
Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement fo...
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), has announced the promotion of Sudhir K...
Biocon said that the US Food and Drug Administration (US FDA) has issued a complete response letter (CRL) for the New Dr...
According to a report by The Pharmaceutical Journal, The majority of warnings from European and US drug ...
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manuf...
Strides Pharma Science Limited (Strides) has announced that its step down subsidiary Strides Pharma Inc.(SPI) has acquir...
Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...
Indian Pharma major Lupin Limited (Lupin) announced that it has received approval for its Hydrocortisone Valerate Cream ...
Indian Pharma major Lupin Limited (including its subsidiaries together referred to as Lupin) announced that ...
Dr. Reddy’s Laboratories Ltd. has announced the launch of Vigabatrin Powder for Oral Solution, USP in 500 mg per p...
